[SciVision] Correction of the Company's Q1 2026 Auditor's Report Opinion Type
Key facts
- [SciVision] Correction of the Company's Q1 2026 Auditor's Report Opinion Type
- SciVision Biotech announced a correction to its Q1 2026 auditor's report, changing the opinion from 'unqualified' to 'qualified' because certain minor subsidiaries were not audited/reviewed.
- Source: PR Times
- Date: May 15, 2026
Direct answer
SciVision Biotech announced a correction to its Q1 2026 auditor's report, changing the opinion from 'unqualified' to 'qualified' because certain minor subsidiaries were not audited/reviewed.
- Citation
- [SciVision] Correction of the Company's Q1 2026 Auditor's Report Opinion Type (May 15, 2026), PR Times
- Source
- PR Times
- Date
- May 15, 2026
SciVision Biotech announced a correction to its Q1 2026 auditor's report, changing the opinion from 'unqualified' to 'qualified' because certain minor subsidiaries were not audited/reviewed.
📋 Article Processing Timeline
- 📰 Published: May 15, 2026 at 09:00
- 🔍 Collected: May 16, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 16, 2026 at 09:13 (1h 13m after Collected)
1. Date of occurrence: 2026/05/15
2. Company name: SciVision Biotech Inc.
3. Relationship to the company: Head office
4. Reciprocal shareholding ratio: N/A
5. Cause of occurrence: Correction of the opinion type in the Company's Q1 2026 auditor's report.
6. Information item to be corrected: Auditor's report opinion type.
7. Before correction: Unqualified conclusion/opinion.
8. After correction: Qualified conclusion/opinion - Other matters - minor subsidiaries or equity-method investments were not audited or reviewed by the CPA.
9. Countermeasures: Re-upload the corrected version to the MOPS.
10. Other matters: None.
2. Company name: SciVision Biotech Inc.
3. Relationship to the company: Head office
4. Reciprocal shareholding ratio: N/A
5. Cause of occurrence: Correction of the opinion type in the Company's Q1 2026 auditor's report.
6. Information item to be corrected: Auditor's report opinion type.
7. Before correction: Unqualified conclusion/opinion.
8. After correction: Qualified conclusion/opinion - Other matters - minor subsidiaries or equity-method investments were not audited or reviewed by the CPA.
9. Countermeasures: Re-upload the corrected version to the MOPS.
10. Other matters: None.
FAQ
What are the key facts in this article?
SciVision Biotech announced a correction to its Q1 2026 auditor's report, changing the opinion from 'unqualified' to 'qualified' because certain minor subsidiaries were not audited/reviewed.
What is the direct answer?
SciVision Biotech announced a correction to its Q1 2026 auditor's report, changing the opinion from 'unqualified' to 'qualified' because certain minor subsidiaries were not audited/reviewed.
What is the source and date?
PR Times: https://mops.twse.com.tw/material/twse-1786-2026-05-15-c56efd57 | May 15, 2026